GETINGE, Sweden--(BUSINESS WIRE)-- Regulatory News:
GETINGE (STO:GETIB) will issue its Q3 report for 2012 on Wednesday 17th of October 2012 at 12:00 CET, followed by a conference call at 15:00 CET, hosted by Johan Malmquist, CEO, and Ulf Grunander, CFO.
To participate in the conference, please dial:
|Swedish dial in number:||+46 (0) 8 5876 9446|
|UK dial in number:||+44 (0) 20 3106 4822|
|US dial in number:||+1 646 254 3366|
|14:45 Call in to the conference|
|15:00 Review of the Q3 report|
|16:00 Close of the conference|
A recorded version of the conference can be accessed for 5 working days on the following number:
|Sweden:||+46 (0) 8 5051 3897|
|UK:||+44 (0) 20 7111 1244|
|US:||+1 347 366 9565|
During the telephone conference a presentation will be held. To access the presentation, please use this link: http://www.livemeeting.com/cc/premconfeurope/join?id=8164231&role=attend&pw=pw5643
Alternatively enter the VisionCast site and log into your meeting using the Meeting ID and Password below:
|Your Name:||(Enter your name)|
|Web Meeting||ID: 8164231|
Web Meeting Password:
GETINGE GROUP is a leading global provider of products and systems that contribute to quality enhancement and cost efficiency within healthcare and life sciences. We operate under the three brands of ArjoHuntleigh, GETINGE and MAQUET. ArjoHuntleigh focuses on patient mobility and wound management solutions. GETINGE provides solutions for infection control within healthcare and contamination prevention within life sciences. MAQUET specializes in solutions, therapies and products for surgical interventions, interventional cardiology and intensive care.
The information is such that Getinge AB must disclose in accordance with the Swedish Securities Market Act and/or the Financial Instruments Trading Act.
This information was brought to you by Cision http://www.cisionwire.com
Phone: +46 (0)10 335 5810
Source: Getinge Group